An exchange for next-generation sequencing
Peter Jabbour, Sponsored by BlueSEQ
A very new company, just went live last month.
What is an exchange? A platform that brings together buyers and sellers within a market. A web portal that helps place researchers, clinicians individuals, etc. with providers of next-gen sequencing services.
[web portals? This seems very 1990s… time warp!]
Why do users need an exchange? Users have limited access, need better access to technology, platvform, application, etc.
Why do providers need an exchange? Providers may want to fill their queues.
[This is one stop shopping for next-gen sequencing providers? How do you make money doing this?]
BlueSEQ platform: 3 parts.
- Knowledge Bank: Comprehensive collection of continuously updated Next Generation Sequencing information, opinons, evaluations, tech bechmarks.
- Project Design: Standardized project parameters. eg, de novo, etc. [How do you standardize the bioinformatics? Seems… naive.]
- Sequencing exchange: Providers get a list of projects that they can bid on.
[wow… not buying this. Keeps referring back to the model with airline tickets.]
Statistics will come out of the exchange – cost of sequencing, etc.
No cost to users. Exchange fees for providers. [again, why would providers want to opt in to this?] 100 users have already signed up.
Future directions: Specialized project desin tools, quoting tools, project management tools, comparison tools, customer reviews.
There are extensive tools for giving feedback, and rating other user’s feedback.
[Sorry for my snarky comments throughout. This just really doesn’t seem like a well thought out business plan. I see TONs of reasons why this shouldn’t work… and really not seeing any why it should. Why would any provider want customer reviews of NGS data… the sample prep is a huge part of the quality, and if they don’t control it, it’s just going to be disaster. I also don’t really see the value added component. Good luck to the business, tho!]